The European Union's pharmaceutical sector is in a perpetual state of evolution. With stringent regulations, growing patient demands, and the accelerated pace of research, navigating this complex landscape requires a prudent approach. Pharmaceutical companies must adapt to this shifts by adopting innovative technologies, partnering with key stakeho